LINCOCIN

This brand name is authorized in Australia, Ecuador, Spain, Japan, Lithuania, Mexico, Poland, Singapore, Turkey

Active ingredients

The drug LINCOCIN contains one active pharmaceutical ingredient (API):

1 Lincomycin UNII M6T05Z2B68 - LINCOMYCIN HYDROCHLORIDE

Lincomycin is an antibiotic produced by fermentation of Streptomyces lincolnensis. Lincomycin inhibits bacterial protein synthesis by binding to the 50S subunit of the bacterial ribosome. Read about Lincomycin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
LINCOCIN Solution for injection	Pharmaceutical Benefits Scheme (AU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J01FF02	Lincomycin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01F Macrolides, lincosamides and streptogramins → J01FF Lincosamides
Discover more medicines within J01FF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2530E, 5144R
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 28675-12-08, 3092-MEE-1117
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 41290, 41468
Country: JP	医薬品医療機器総合機構	Identifier(s): 6112003M1030, 6112400A2030, 6112400A4075, 6112400A6086, 6112400A7031
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1006093, 1010486
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 62014, 62016, 65768
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100033597, 100037684
Country: SG	Health Sciences Authority	Identifier(s): 01716P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308751027